Another solid quarter for NxStage Medical

May 8, 2012 by MassDevice staff

NxStage Medical posts a double-digit top-line increase and narrows its 1st-quarter losses but closes down more than 3%, possibly due to a debt-to-equity swap by Asahi Kasei. news

Investors declined to reward NxStage Medical (NSDQ:NXTM) today for another in a string of solid quarters, sending share prices down YY% despite higher sales, narrowed losses and re-affirmed guidance.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.